Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease

European Journal of Neuroscience

Volumn 32, Issue 1, 2010, Pages 71-79

  Noristani, H N ^a   Olabarria, M ^a   Verkhratsky, A ^a,b   Rodriguez J J ^a,b,c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Alzheimer's disease; hippocampus; plasticity; raphe nucleus; serotonin; serotonin transporter

Indexed keywords

AMYLOID BETA PROTEIN; SEROTONIN TRANSPORTER;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DISEASE COURSE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNERVATION; MALE; MOUSE; NERVE SPROUTING; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAPHE NUCLEUS; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE FIBERS; PLAQUE, AMYLOID; RAPHE NUCLEI; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 77954406030     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07274.x     Document Type: Article

References (64)

1. Albright, M.J., Weston, M.C., Inan, M., Rosenmund, C. Crair, M.C. (2007) Increased thalamocortical synaptic response and decreased layer IV innervation in GAP-43 knockout mice. J. Neurophysiol., 98, 1610 1625.
2. Azmitia, M.P. (2001) Serotonin and brain development: role in human developmental diseases. Brain Res. Bull., 56, 479 485.
3. Birks, J.S., Melzer, D. Beppu, H. (2008) Donepezil for mild and moderate Alzheimer's disease. Cochrane Database Syst. Rev., 4, 1 140.
4. Bjarkam, R.C., Sørensen, C.J. Geneser, A.F. (2005) Distribution and morphology of serotonin-immunoreactive axons in the retrohippocampal areas of the New Zealand white rabbit. Anat. Embryol., 210, 199 207.
5. Bowen, M.D., Procter, W.A., Mann, A.M.D., Snowden, S.J., Esiri, M.M., Neary, D. Francis, P.T. (2008) Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology, 196, 603 610.
6. Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H. Braak, H. (1999) Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur. Arch. Psychiatry Clin. Neurosci., 249, 14 22.
7. Bregman, B.S., McAtee, M., Dai, H.N. Kuhn, P.L. (1997) Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp. Neurol., 48, 475 494.
8. 2+influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol., 26, 325 338.
9. Burbach, G.J., Hellweg, R., Haas, C.A., Del Turco, D., Deicke, U., Abramowski, D., Jucker, M., Staufenbiel, M. Deller, T. (2004) Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J. Neurosci., 24, 2421 2430.
10. 11C]DASB; comparison with bipolar disorder. Biol. Psychiatry, 62, 870 877.
11. Chen, C.P., Eastwood, S.L., Hope, T., McDonald, B., Francis, P.T. Esiri, M.M. (2000) Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol. Appl. Neurobiol., 26, 347 355.
12. Clinton, K.L., Billings, M.L., Green, N.K., Caccamo, A., Ngo, J., Oddo, S., McGaugh, J.L. LaFerla, F.M. (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol. Dis., 28, 76 82.
13. Cordero, M.I., Rodríguez, J.J., Davies, H.A., Peddie, C.J., Sandi, C. Stewart, M.G. (2005) Chronic restraint stress down-regulates amygdaloid expression of polysialylated neural cell adhesion molecule. Neuroscience, 133, 903 910.
14. Evers, E.A., van der Veen, F.M., Fekkes, D. Jolles, J. (2007) Serotonin and cognitive flexibility: neuroimaging studies into the effect of acute tryptophan depletion in healthy volunteers. Curr. Med. Chem., 14, 2989 2995.
15. Frazer, E.M., Hughes, E.J., Mastrangelo, A.M., Jennifer, L., Tibbens, L.J., Federoff, J.H. Bowers, W.J. (2008) Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-β and Interleukin-4. Mol. Ther., 16, 845 853.
16. Garcia-Alloza, M., Gil-Bea, F.J., Diez-Ariza, M., Chen, C.P., Francis, P.T., Lasheras, B. Ramirez, M.J. (2005) Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia, 43, 442 449.
17. Gasser, U.E. Dravid, A.R. (1987) Noradrenergic, serotonergic, and cholinergic sprouting in the hippocampus that follows partial or complete transection of the septohippocampal pathway: contributions of spared inputs. Exp. Neurol., 96, 352 364.
18. Gerlai, R. Roder, J. (1996) Spatial and non-spatial learning in mice: effects of S100 beta overexpression and age. Neurobiol. Learn. Mem., 66, 143 154.
19. Grider, M.H., Mamounas, L.A., Le, W. Shine, H.D. (2005) In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J. Neurosci. Res., 82, 404 412.
20. Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L., 3rd. Araoz, C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA, 86, 7611 7615.
21. 2+antagonist nimodipine. Neuroscience, 101, 101 114.
22. (1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiol. Dis., 8, 667 678.
23. 2A receptor binding in patients with mild cognitive impairment. Neurobiol. Aging, 29, 1830 1838.
24. Hensler, J.G. (2006) Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev., 30, 203 214.
25. 1A receptors in the living brain of Alzheimer's disease patients. Proc. Natl. Acad. Sci. USA, 103, 702 707.
26. Keuker, J.I., Keijser, J.N., Nyakas, C., Luiten, P.G. Fuchs, E. (2005) Aging is accompanied by a subfield-specific reduction of serotonergic fibers in the tree shrew hippocampal formation. J. Chem. Neuroanat., 30, 221 229.
27. Konigsmark, B.W. (1970) Methods for the counting of neurones. In Nauta, W.J.H. Ebbesson S.O.E. (Eds Contemporary Research Methods in Neuroanatomy. Springer-Verlag
28. Lai, M.K., Tsang, S.W., Francis, P.T., Keene, J., Hope, T., Esiri, M.M., Spence, I. Chen, C.P. (2002) Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease. Neuroreport, 13, 1175 1178.
29. Liu, Y., Yoo, M.J., Savonenko, A., Stirling, W., Price, D.L., Borchelt, D.R., Mamounas, L., Lyons, W.E., Blue, M.E. Lee, M.K. (2008) Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J. Neurosci., 28, 13805 13814.
30. 6 receptors in the prefrontal cortex of Alzheimer and normal aging patients. BMC Neurosci., 27, 7 36.
31. Luellen, A.B., Bianco, E.L., Schneider, M.L. Andrews, M.A. (2007) Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav., 6, 482 490.
32. Mamounas, L.A., Altar, C.A. Blue, M.E. (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci., 20, 771 782.
33. Meltzer, C.C., Smith, G., DeKosky, S.T., Pollock, B.G., Mathis, C.A., Moore, R.Y., Kupfer, D.J. Reynolds, C.F. 3rd. (1998) Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology, 18, 407 430.
34. Miguel-Hidalgo, J.J., Alvarez, X.A., Cacabelos, R. Quack, G. (2002) Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res., 958, 210 221.
35. Moreno, H., Wu, W.E., Lee, T., Brickman, A., Mayeux, R., Brown, T.R. Small, S.A. (2007) Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch. Neurol., 64, 1467 1477.
36. Mossello, E., Boncinelli, M., Caleri, V., Cavallini, M.C., Palermo, E., Di Bari, M., Tilli, S., Sarcone, E., Simoni, D., Biagini, C.A., Masotti, G. Marchionni, N. (2008) Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 25, 372 379.
37. Mowla, A., Mosavinasab, M., Haghshenas, H. Haghighi, B.A. (2007) Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? J. Clin. Psychopharmacol., 27, 484 487.
38. Murer, M.G., Yan, Q. Raisman-Vozari, R. (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol., 3, 71 124.
39. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. LaFerla, F.M. (2003a) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A and synaptic dysfunction. Neuron, 39, 409 421.
40. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B.P. LaFerla, F.M. (2003b) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging, 24, 1063 1070.
41. Olabarria, M., Noristani, H.N., Verkhratsky, A. Rodríguez, J.J. (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia., 58, 831 838.
42. Paxinos, G. Franklin, K.B.J. (2004) The mouse Brain in Stereotaxic Coordinates, Compact, 2nd edn. Academic Press
43. B receptors and the glutamate NMDA receptor subunit NR1 within the hippocampal dentate gyrus: an ultrastructural study. J. Chem. Neuroanat., 36, 17 26.
44. Phinney, A.L., Deller, T., Stalder, M., Calhoun, M.E., Frotscher, M., Sommer, B., Staufenbiel, M. Jucker, M. (1999) Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci., 19, 8552 8559.
45. Pickel, V.M., Johnson, E., Carson, M. Chan, J. (1992) Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Dev. Brain Res., 70, 75 86.
46. Porter, R.J., Lunn, B.S., Walker, L.L., Gray, J.M., Ballard, C.G. O'Brien, J.T. (2000) Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease. Am. J. Psychiatry, 157, 638 640.
47. Rodríguez, J.J., Jones, C.V., Tabuchi, M., Allan, M.S., Knight, M.E., LaFerla, M.F., Oddo, S. Verkhratsky, A. (2008) Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS ONE, 3, e2935.
48. Rodríguez, J.J., Olabarria, M., Chvatal, A. Verkhratsky, A. (2009a) Astroglia in dementia and Alzheimer's disease. Cell Death Differ., 16, 378 385.
49. Rodríguez, J.J., Jones, C.V. Verkhratsky, A. (2009b) Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model. Neuroreport, 20, 907 912.
50. Salinero, O., Moreno-Flores, M.T. Wandosell, F. (2000) Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease. J. Neurosci. Res., 60, 87 97.
51. Scheff, S.W., Price, D.A., Schmitt, F.A. Mufson, E.J. (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging, 27, 1372 1384.
52. Schmitt, J.A., Wingen, M., Ramaekers, J.G., Evers, E.A. Riedel, W.J. (2006) Serotonin and human cognitive performance. Curr. Pharm., 12, 2473 2486.
53. Spires, T.L., Meyer-Luehmann, M., Stern, E.A., McLean, P.J., Skoch, J., Nguyen, P.T., Bacskai, B.J. Hyman, B.T. (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci., 25, 7278 7287.
54. Terry, A.V. Jr., Buccafusco, J.J. Wilson, C. (2008) Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets. Behav. Brain Res., 195, 30 38.
55. Thomas, A.J., Hendriksen, M., Piggott, M., Ferrier, I.N., Perry, E., Ince, P. O'Brien, J.T. (2006) A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathol. Appl. Neurobiol., 32, 296 303.
56. Tohgi, H., Abe, T., Takahashi, S., Saheki, M. Kimura, M. (1995) Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J. Neural. Transm., 9, 121 131.
57. Truchot, L., Costes, S.N., Zimmer, L., Laurent, B., Le Bars, D., Thomas-Antérion, C., Croisile, B., Mercier, B., Hermier, M., Vighetto, A. Krolak-Salmon, P. (2007) Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment. Neurology, 69, 1012 1017.
58. Verdurand, M., Bérod, A., Le Bars, D. Zimmer, L. (2009) Effects of amyloid-beta peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus. Neurobiol. Aging, doi :.
59. Vertes, R.P. (1991) A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol., 313, 643 668.
60. Vertes, R.P. Crane, A.M. (1997) Distribution, quantification, and morphological characteristics of serotonin-immunoreactive cells of the supralemniscal nucleus (B9) and pontomesencephalic reticular formation in the rat. J. Comp. Neurol., 378, 411 424.
61. Vertes, R.P., Fortin, W.J. Crane, A.M. (1999) Projections of the median raphe nucleus in the rat. J. Comp. Neurol., 407, 555 582.
62. Whitaker-Azmitia, M.P., Wingate, M., Borella, A. Gerlai, R. (1997) Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioural signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res., 776, 51 60.
63. Zhou, F.C., Azmitia, E.C. Bledsoe, S. (1995) Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus. Brain Res. Dev. Brain Res., 84, 89 98.
64. Zhou, F.C., Sari, Y. Zhang, J.K. (2000) Expression of serotonin transporter protein in developing rat brain. Dev. Brain Res., 119, 33 45.